UK liquid biopsy company ANGLE plc has filed a de novo submission with the US Food & Drug Administration for its Parsortix system to capture metastatic breast tumor cells
The system is designed to harvest circulating tumor cells (CTC's) from a patient’s blood sample with a microfluidic cassette . As the blood flows through the system, the cancer cells...